NFE2L2 and psoriasis: Besides, rapamycin, an inhibitor of mTOR, could exert antiproliferative properties in the imiquimod (IMQ)-induced mice psoriasis via activating NRF2 signaling and restraining NOX2/4 from decreasing ROS generation [40].